scholarly journals Natural History, Ecology, and Management of the Mexican Bean Beetle (Coleoptera: Coccinellidae) in the United States

2016 ◽  
Vol 7 (1) ◽  
pp. 2 ◽  
Author(s):  
L. B. Nottingham ◽  
G. P. Dively ◽  
P. B. Schultz ◽  
D. A. Herbert ◽  
T. P. Kuhar
2008 ◽  
Vol 12 (1) ◽  
Author(s):  
Anthony G Picciano ◽  
Robert V. Steiner

Every child has a right to an education. In the United States, the issue is not necessarily about access to a school but access to a quality education. With strict compulsory education laws, more than 50 million students enrolled in primary and secondary schools, and billions of dollars spent annually on public and private education, American children surely have access to buildings and classrooms. However, because of a complex and competitive system of shared policymaking among national, state, and local governments, not all schools are created equal nor are equal education opportunities available for the poor, minorities, and underprivileged. One manifestation of this inequity is the lack of qualified teachers in many urban and rural schools to teach certain subjects such as science, mathematics, and technology. The purpose of this article is to describe a partnership model between two major institutions (The American Museum of Natural History and The City University of New York) and the program designed to improve the way teachers are trained and children are taught and introduced to the world of science. These two institutions have partnered on various projects over the years to expand educational opportunity especially in the teaching of science. One of the more successful projects is Seminars on Science (SoS), an online teacher education and professional development program, that connects teachers across the United States and around the world to cutting-edge research and provides them with powerful classroom resources. This article provides the institutional perspectives, the challenges and the strategies that fostered this partnership.


2019 ◽  
Vol 71 (1) ◽  
pp. 53-62 ◽  
Author(s):  
Gloria H Hong ◽  
Ana M Ortega-Villa ◽  
Sally Hunsberger ◽  
Ploenchan Chetchotisakd ◽  
Siriluck Anunnatsiri ◽  
...  

Abstract Background The natural history of anti-interferon-γ (IFN-γ) autoantibody-associated immunodeficiency syndrome is not well understood. Methods Data of 74 patients with anti-IFN-γ autoantibodies at Srinagarind Hospital, Thailand, were collected annually (median follow-up duration, 7.5 years). Annual data for 19 patients and initial data for 4 patients with anti-IFN-γ autoantibodies at the US National Institutes of Health were collected (median follow-up duration, 4.5 years). Anti-IFN-γ autoantibody levels were measured in plasma samples. Results Ninety-one percent of US patients were of Southeast Asian descent; there was a stronger female predominance (91%) in US than Thai (64%) patients. Mycobacterium abscessus (34%) and Mycobacterium avium complex (83%) were the most common nontuberculous mycobacteria in Thailand and the United States, respectively. Skin infections were more common in Thailand (P = .001), whereas bone (P < .0001), lung (P = .002), and central nervous system (P = .03) infections were more common in the United States. Twenty-four percent of Thai patients died, most from infections. None of the 19 US patients with follow-up data died. Anti-IFN-γ autoantibody levels decreased over time in Thailand (P < .001) and the United States (P = .017), with either cyclophosphamide (P = .01) or rituximab therapy (P = .001). Conclusions Patients with anti-IFN-γ autoantibodies in Thailand and the United States had distinct demographic and clinical features. While titers generally decreased with time, anti-IFN-γ autoantibody disease had a chronic clinical course with persistent infections and death. Close long-term surveillance for new infections is recommended.


Ecology ◽  
1957 ◽  
Vol 38 (3) ◽  
pp. 548
Author(s):  
Charles M. Bogert ◽  
Albert Hazen Wright ◽  
Anna Allen Wright

2013 ◽  
Vol 145 (6) ◽  
pp. 603-625 ◽  
Author(s):  
Mar Ferrer-Suay ◽  
Jesús Selfa ◽  
Juli Pujade-Villar

AbstractAlloxysta Förster, 1869 (Hymenoptera: Figitidae) type material of 19 nominal species deposited in the Canadian National Collection of Insects (Ottawa, Ontario, Canada) and the United States National Museum of Natural History (Washington, District of Columbia, United States of America) were studied. Nine species are treated as valid: A. australiae (Ashmead, 1900), A. commensuratus Andrews, 1978, A. japonicus (Ashmead, 1904), A. lachni (Ashmead, 1885), A. longiventris Baker, 1896, A. minuscula Andrews, 1978, A. nothofagi Andrews, 1976, A. vandenboschi Andrews, 1978, and A. xanthopsis (Ashmead, 1896). The following synonymies are established: A. affinis (Baker, 1896) and A. quebeci Andrews, 1978 junior synonyms of A. castanea (Hartig, 1841); A. alaskensis Ashmead, 1902 and A. coniferensis Andrews, 1978 junior synonyms of A. macrophadna (Hartig, 1841); A. bicolor (Baker, 1896) and A. anthracina Andrews, 1978 junior synonyms of A. obscurata (Hartig, 1840); A. dicksoni Andrews, 1978 junior synonym of A. pilipennis (Hartig, 1840); and A. leguminosa (Weld, 1920), A. megourae (Ashmead, 1887), and A. rauchi Andrews, 1978 junior synonyms of A. brevis (Thomson, 1862). The type material of A. schlingeri Andrews, 1978 and A. halli Andrews, 1978 could not be found and we consider them as nomina dubia. Alloxysta vandenboschi Andrews is removed from synonymy with A. obscurata and considered a valid species. Comments on the type material are given. Complete redescriptions and images are presented for the valid species.


2018 ◽  
pp. 422-428
Author(s):  
S. Nassir Ghaemi

Until the 1960s, physicians in the United States could legally prescribe “placebo” on a prescription pad and handed to a patient. It was not unethical to do so. Placebo had long been known to be an effective treatment for various medical conditions. For millennia, physicians new that many of their treatments were ineffective and that many conditions could not be treated. Instead of giving treatments that have some pharmacological properties, which meant they would have some side effects and be harmful in some way, it was viewed as more ethical to give an inert pill, a placebo, which would cause no direct pharmacological harm. The view was that the patient might get some psychological benefit from the apparent treatment. The placebo response involves two major aspects: natural history and psychological expectation. Too much attention is given to the latter and not enough to the former. Clinicians see patients improve, as in acute depressive episodes, due to natural history, but they attribute such benefit to the drugs they use, or their psychotherapeutic relationship. Often Nature deserves the credit, and clinicians need to pay more attention to the natural course of psychiatric illnesses.


Author(s):  
Yuli Y. Kim ◽  
Michael J. Landzberg ◽  
Anne Marie Valente

Historically, individuals with complex congenital heart disease rarely lived past childhood. Due to tremendous advances in diagnosis and treatment, now 85–90% of children born with congenital heart disease will survive into adulthood. Estimates suggest that over 1 million adults with congenital heart disease currently live in the United States. The number of adults with congenital heart disease (ACHD) is growing by approximately 5% each year. The majority of these patients do not appear to be followed by ACHD specialists. Therefore, it is essential that all physicians familiarize themselves with the unique clinical presentations of these patients, including the anatomy, physiology, and natural history in order to facilitate proper management and referral.


Sign in / Sign up

Export Citation Format

Share Document